Charles N II York
CIK 1655962 · COO and CFO · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
42
Lifetime Open-Market Net
-$3.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | COO and CFO | 0 | $21.53 | $0 | -$3.32M | 34 | 2026-04-23 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Chief Financial Officer and VP | 46,347 | $12.01 | $556.6K | $116.2K | 8 | 2020-02-19 |
Recent Filings · Page 4 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-20 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −2,500 | -$50.0K | EDGAR |
| 2022-07-12 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −1,416 | -$28.3K | EDGAR |
| 2022-07-06 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −2,279 | -$45.6K | EDGAR |
| 2022-01-20 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-19 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-01 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-22 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-05 | Spyre Therapeutics, Inc. (AGLE) Delisted | Buy (P) | +25,959 | $116.2K | EDGAR |
| 2017-08-24 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-22 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.